Sales Representative
First AmericanFull Time
Junior (1 to 2 years)
Santa Rosa, California, United States
Key technologies and capabilities for this role
Common questions about this position
The pay range is $140,000 - $155,000, though the final offer may vary based on factors like geographic location, job-related knowledge, skills, experience, and education.
The role is for the North Bay, CA territory, requiring up to 100% travel including 40% overnight.
Requirements include a BA/BS or equivalent and 5+ years of sales experience, with recent endocrine relationships, specialty therapeutic, hospital, or orphan drugs sales highly preferred. Preferred skills include a proven track record of high performance, strong cross-functional collaboration, ability to travel up to 100% (40% overnight), maintaining a driving record per company policy, and lifting up to 35 pounds.
Corcept leads in research and development of cortisol modulators for serious diseases, with FDA-approved Korlym® for Cushing’s syndrome and over 30 ongoing studies. The sales role involves building relationships with prescribers, implementing strategies compliantly, and managing territory plans in a collaborative team environment.
Candidates with 5+ years of sales experience, especially in endocrinology, specialty therapeutics, hospitals, or orphan drugs, a proven track record of high performance, and strong cross-functional collaboration skills stand out. Experience building relationships with high prescribers and managing territories effectively is key.
Develops cortisol modulators for medical conditions
Corcept Therapeutics focuses on developing treatments that regulate cortisol levels in the body, which is important for managing various health issues. Their main product, Korlym, is used to treat Cushing's syndrome, a condition caused by too much cortisol. Korlym was approved by the FDA in 2012 and is the first medication specifically for this disorder. Corcept stands out from competitors by having a strong emphasis on research and development, having discovered over 1,000 unique cortisol modulators. The company aims to expand its range of treatments while also providing educational resources to healthcare professionals and patients to improve understanding and care for cortisol-related conditions.